As of Jan 20
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Meridian Bioscience Inc have a median target of 18.00, with a high estimate of 18.00 and a low estimate of 15.00. The median estimate represents a +7.46% increase from the last price of 16.75.
The current consensus among 6 polled investment analysts is to Hold stock in Meridian Bioscience Inc. This rating has held steady since January, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.